Chair Sarcoma Service - Head of the Department of Surgery
Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
Alessandro Gronchi MD received his MD degree from Milan University in 1992, completed his residency training in General Surgery in 1997 and a fellowship in Surgical Oncology in 1998. He holds the National Scientific qualification for full professor of General Surgery. He is chair of the Sarcoma Service since 2001 and head of the department of Surgery since 2022 at the National Cancer Institute – Milan – Italy.
He runs the institutional Sarcoma Data Base, which gathers information on over 10000 patients affected by soft tissue sarcoma (STS), desmoid-fibromatosis (DF) and GIST. He is involved in all institutional research activities on sarcoma, which include neoadjuvant therapies in extremity and retroperitoneal sarcomas, new targets for specific STS types, genomic characterization of DF and its impact on tumor progression, mechanisms of resistance to therapy in GIST. He is the Principal Investigator of several Italian and International trials on STS, DF and GIST.
He serves as member of the board of directors of Italian Sarcoma Group and of European Society of Surgical Oncology 2020-2024; international representative on the executive council of SSO 2021-2024; member of the Sarcoma Task Force of European Society for Medical Oncology. He was chair of the EORTC Soft Tissue and Bone Sarcoma Group (2015-2017), president of Connective Tissue Oncology Society (2016); president of Italian Society of Surgical Oncology (2019-2021). He is member of European Surgical Association, American Society of Clinical Oncology and honorary member of Polish Society of Surgical Oncology. He is one of the initiators of the Trans-atlantic Australasian RetroPeritoneal Sarcoma Working Group, which involves over 160 institutions worldwide. Dr. Gronchi has authored more than 470 scientific publications (Scopus HIndex 89), serves as Associate Editor of Annals of Surgical Oncology, Journal of Surgical Oncology, Critical Reviews in Oncology/Hematology, Ther Adv Med Oncol.